Opus Genetics Inc (IRD)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.67+1.52%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · IRD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 9.9 | 14.2 | 11.0 | 19.0 | 39.9 | 0.6 | 0.0 | 3.0 | — | — | — | — | — | 0.0 | — | 0.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | — | 0.0 |
| Cost of Revenues | — | — | — | — | — | — | — | — | 0.1 | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | — | — | — | — | — | — | — | 5.5 | 13.1 | 10.7 | 10.1 | 12.1 | 7.0 | 3.3 | 3.4 | 12.0 |
| Operating Income | (50.6) | (38.6) | (62.1) | (10.6) | 18.2 | (22.7) | (20.0) | (4.2) | (20.5) | (17.4) | (16.4) | (18.3) | (13.3) | (8.0) | (6.6) | (16.1) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 0.1 | — | 0.0 | 0.0 | 0.0 | 6.8 | — | — | — | — | — | — | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | — | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | 2.6 | 6.2 | (7.9) | 7.1 | 3.9 | (5.3) | (1.5) | 0.4 | 4.8 |
| EBT, Incl. Unusual Items | (107.6) | (49.6) | (57.5) | (10.0) | 18.2 | (56.7) | (24.6) | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.3 | 0.0 | 0.0 | — | — | — | — | — | — | 0.0 | — | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | (107.6) | (49.6) | (57.5) | (10.0) | 17.9 | (56.7) | (24.6) | (6.2) | (14.4) | (25.3) | (9.3) | (14.4) | (18.5) | (9.5) | (6.2) | (11.3) |
| Per Share | ||||||||||||||||
| Basic EPS | (1.13) | (0.80) | (2.15) | (0.46) | 0.90 | (3.82) | (5.28) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.97) | (0.80) | (2.15) | (0.46) | 0.87 | (3.82) | (5.28) | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 0.09 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 95.5 | 62.2 | 26.7 | 21.6 | 19.9 | 14.9 | 4.7 | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 111.4 | 62.2 | 26.7 | 21.6 | 20.6 | 14.9 | 4.7 | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | — | — | — | — | — | — | (4.2) | (20.5) | (17.3) | (16.4) | (18.2) | (13.2) | (7.9) | (6.5) | (16.1) |
| EBIT | (50.6) | (38.6) | (62.1) | (10.6) | 18.2 | (22.7) | (20.0) | (4.2) | (20.5) | (17.4) | (16.4) | (18.3) | (13.3) | (8.0) | (6.6) | (16.1) |
| Effective Tax Rate | — | — | — | -0.1% | 1.7% | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.